Abstract
Comment on Tang et al. 2021. Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study. Lancet Reg Health West Pac; 14:100226. https://doi.org/10.1016/j.lanwpc.2021.100226.
Of all the shockwaves sustained by health services around the globe following the COVID-19 pandemic, one of the most profound and enduring has occurred in the context of cancer. Regardless of how endemic COVID-19 has been within a given population, cancer services the world-over have had to rapidly adapt and respond to a changing care delivery environment. Each care discipline has faced its own unique challenges, particularly during the on again-off again lockdowns; and in the context of the ongoing provision of systemic cancer therapy, a key hurdle has been disruptions to care access within the usual clinic environment.